Stimulant Treatment for ADHD Not Associated With Increased Risk of Cardiac Events in Youth, New York State Psychiatric Institute and Columbia University Study

2/9/2012 7:07:57 AM

Attention-deficit/hyperactivity disorder (ADHD) affects 5-9% of youth and is frequently treated with stimulant medications, such as methylphenidate and amphetamine products. A recent safety communication from the US Food and Drug Administration advised that all patients undergoing ADHD treatment be monitored for changes in heart rate or blood pressure.

Read at EurekAlert!

Read Article at

Related Companies

News Categories

• EurekAlert!

• Columbia University

• New York State Psychiatric Institute

• Academic / Research - Research news

• Clinical - Research